Whitney & Co’s Loxo Oncology, Inc LOXO Stock Holding History

Whitney & Co’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9	Closed	-$2K	–	534
2018 Q3	$2K	Buy	+9	New	+$1.51K	﹤0.01%	495

Other funds holding LOXO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Whitney & Co's LOXO Position: Q4 2018 in Review

Whitney & Co sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 9 shares — an estimated $2K sold.

Whitney & Co first reported a position in LOXO in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

Whitney & Co reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
Whitney & Co sold 9 Loxo Oncology, Inc shares in Q4 2018, an estimated $2K.
Whitney & Co first reported a position in Loxo Oncology, Inc in Q3 2018 and held it in 1 quarter.
Whitney & Co's Loxo Oncology, Inc position peaked at $2K in Q3 2018.
232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Whitney & Co's 13F filing for Q4 2018, filed 7 Feb 2019.